Skip to content
‹ Back to IndustriesHealthcare

Scaling Clinical Diagnostic Testing to the Masses (Part 2)

The rising cost of health care has hit Americans differently depending on their economic status. There is no shortage of news stories covering the reality of  those with higher incomes having higher life expectancies than those in lower financial brackets. Healthcare services such as clinical diagnostic testing may be out of reach for those who…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

The rising cost of health care has hit Americans differently depending on their economic status. There is no shortage of news stories covering the reality of those with higher incomes having higher life expectancies than those in lower financial brackets. Healthcare services such as clinical diagnostic testing may be out of reach for those who could really use it. So what are some the things a company can do to make clinical diagnostic testing more accessible for everyone? How can an important medical test be affordable to all?

On this episode of Health & Life Sciences at the Edge, host Michelle Dawn Mooney talks with Intel Head of Business Innovation and Life Science Specialist Blake Harlan and SiPhox Chief Product Officer Mike Dubrovsky about clinical diagnostic testing, the way it is used, and the way its use can be improved.

“Clinical diagnostic testing is actually a major part of the [healthcare] system,” says Dubrovsky. “Seventy percent of all medical decisions require diagnostic tests. However, the way that it’s done now is very reactive, so the whole system is based on first the patient having symptoms and then they’re put through a series of tests to try to resolve the problem.” Harlan and Dubrovsky further mention how it’s easy for those in higher income brackets to get tested more often, as those types of tests cost much more than the ones for reactive patients who are presently experiencing symptoms.

“The way the healthcare system works now is it’s really set up to, for the person, once they get sick, to deal with that” says Dubrovsky. He points out how the system is primarily designed to treat reactive care. “The problem is that there is a massive rise in healthcare costs, accompanied with actually a decrease in life expectancy, at least in America”, where six out of ten Americans have at least one chronic disease. In a country that spends so much on healthcare research, Harlan and Dubrovsky think the country needs to shift its thinking and policies when it comes to the health of its citizens.

Learn more about network operations center solutions by connecting with Blake Harlan and Mike Dubrovsky on LinkedIn or visiting SiPhox or Intel Health and Life Sciences.

Subscribe to this channel on Apple Podcasts, Spotify, and Google Podcasts to hear more from the Intel Network and Edge Solutions Group.

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Suki raises $90M to take its AI scribe beyond note-taking

Suki raises $90M to take its AI scribe beyond note-taking

The funding backs a bet that scribes become clinicians' main AI interface, which changes how health systems evaluate them.

  • 01An ambient scribe already holds the patient context from the visit, and in early testing that context drove clinicians to prefer context-aware UpToDate answers 83% of the time.
  • 02Once a scribe starts answering clinical questions, note accuracy stops being enough to judge it. The Suki and Regenstrief evaluation framework is the marker to watch for metrics that cover answers too.

Oct 15, 2026

Harbor Health to buy 27 Village Medical clinics in Greater Houston

Harbor Health to buy 27 Village Medical clinics in Greater Houston

Harbor Health's purchase of Village Medical clinics in Houston is expected to close at the end of 2026. The 27 clinics are the primary care home for Harbor members in four counties.

  • 01Harbor's $0 specialist benefit only applies when a Harbor clinician makes the referral. For Houston employers, the test is whether employees will use the 27 clinics as their first stop.

Oct 8, 2026

SCI recruits funeral sales as the career AI cannot replace

SCI recruits funeral sales as the career AI cannot replace

SCI's recruiting video positions funeral and cremation sales as a career resistant to automation by emphasizing the human trust required in end-of-life planning. The pitch frames the role as requiring both compassion and sales drive, targets people outside the industry, and leans on demographic demand from an aging population to argue for job stability.

  • 01More than 11,000 Americans turn 65 daily, SCI says demand will grow.
  • 02SCI seeks candidates with dual traits: compassion and empathy alongside sales-oriented drive and tenacity.
  • 03The role requires no prior industry experience; SCI provides training, coaching, and technology to prepare newcomers.

Oct 7, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512